Yiqi Huoxue Yangyin Decoction Ameliorates Diabetic Nephropathy by Targeting AMPK/mTOR-Mediated Autophagy: A Network Pharmacology-Guided in vivo and in vitro Study
Diabetes, Metabolic Syndrome and Obesity · 2026-09 · Volume 19 · 1-20
DOI: 10.2147/dmso.s584822 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Metabolic Syndrome and Obesity, 2026-09. Verfasst von ZhiWei Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jinhua Academy, Zhejiang Chinese Medical University, Jinhua, Zhejiang, 321000, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
This study aimed to investigate the protective effects and underlying mechanisms of Yiqi Huoxue Yangyin Decoction (YHY), a multi-herb formula composed of Astragalus membranaceus, Ligusticum chuanxiong, Pueraria lobata, Rehmannia glutinosa, and Trichosanthes kirilowii, against diabetic nephropathy (DN), focusing on its role in modulating autophagy and attenuating podocyte senescence via the AMPK/mTOR signaling pathway. Materials and Methods: Using network pharmacology and UPLC-Q-TOF-MS, this study examined the active constituents and targets of YHY. The type 2 diabetes db/db mouse model (leptin receptor-deficient BKS.Cg-Lepr /+ mice, random blood glucose ≥ 16.7 mmol/L) was used to construct a DN model in vivo. Mice received daily oral gavage of YHY or vehicle for 4 weeks (n=10). YHY's protective benefits were assessed by physiological measurements, serum insulin and HbA1c by ELISA, histopathological evaluation of glomerular and tubular regions, glomerular basement membrane thickness by TEM, and protein expression in renal cortex by immunohistochemistry, immunofluorescence, and Western blot. In vitro, using a high-glucose-induced MPC-5 model, CCK-8, wound healing assays, qRT-PCR, and Western blot were performed (n=3-6) to investigate the mechanisms of YHY.
Results
YHY demonstrated significant protective effects against DN. The expression levels of autophagy markers (ULK1, P62, and LC3B) in renal tissue were restored following YHY intervention. Through the AMPK/mTOR pathway, YHY regulated the expression of autophagy-related genes (ULK1, Beclin-1, P62, LC3B, ATG5, ATG7) and senescence-related genes (P21, P53), and improved the survival and migratory capabilities of high-glucose-induced MPC-5 cells. Furthermore, YHY enhanced the expression of podocyte structural proteins, including Nephrin, NPHS2, and SYNPO.
Conclusion
YHY treatment was associated with activation of autophagy and attenuation of podocyte senescence, potentially through modulation of the AMPK/mTOR signaling pathway, a finding that requires validation in future mechanistic studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Jinhua Academy, Zhejiang Chinese Medical University, Jinhua, Zhejiang, 321000, People's Republic of China.
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, People's Republic of China.
- Zhuji Hospital of Traditional Chinese Medicine, Zhuji, Zhejiang, 311800, People's Republic of China.
- Hangzhou Traditional Chinese Medicine Hospital, Hangzhou, Zhejiang, 310053, People's Republic of China.
- Hangzhou Lin'an Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang, 311300, People's Republic of China.
- School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, People's Republic of China.
ORCID-Profile: WenHong Liu
Zitieren
APA
Xu, Z., He, J., Zhang, Y., Jin, J., Pan, F., Mi, A., Peng, X., Liu, W., Yang, Y., & Wang, H. (2026). Yiqi Huoxue Yangyin Decoction Ameliorates Diabetic Nephropathy by Targeting AMPK/mTOR-Mediated Autophagy: A Network Pharmacology-Guided in vivo and in vitro Study. Diabetes, Metabolic Syndrome and Obesity, Volume 19, 1-20. https://doi.org/10.2147/dmso.s584822
Vancouver
Xu Z, He J, Zhang Y, Jin J, Pan F, Mi A, et al. Yiqi Huoxue Yangyin Decoction Ameliorates Diabetic Nephropathy by Targeting AMPK/mTOR-Mediated Autophagy: A Network Pharmacology-Guided in vivo and in vitro Study. Diabetes, Metabolic Syndrome and Obesity. 2026;Volume 19:1-20. doi:10.2147/dmso.s584822
BibTeX
@article{Xu2026,
author = {Xu, ZhiWei and He, JinXing and Zhang, Yangli and Jin, JianHong and Pan, Fei and Mi, Ai and Peng, XueQian and Liu, WenHong and Yang, YanFang and Wang, Hui},
title = {Yiqi Huoxue Yangyin Decoction Ameliorates Diabetic Nephropathy by Targeting AMPK/mTOR-Mediated Autophagy: A Network Pharmacology-Guided in vivo and in vitro Study},
journal = {Diabetes, Metabolic Syndrome and Obesity},
year = {2026},
volume = {Volume 19},
pages = {1--20},
doi = {10.2147/dmso.s584822}
}
EUVIMED